13.09.2017
- After a protracted search, Israeli generics giant Teva has appointed a new president and chief executive officer. Kåre Schultz will take over from interim CEO Yitzhak Peterburg at...
31.08.2017
- Three weeks after announcing it would cut 350 jobs at two plants in Israel, generics producer Teva has trimmed the number back to 285. The company said it will only eliminate 65...
08.08.2017
- As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...
10.02.2017
- Israeli drugmaker – the world’s largest generics producer – has moved into the spotlight again, days after it said it was replacing its CEO Erez Vigodman. According to the Israeli...
08.02.2017
- Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...
09.12.2016
- Shares of Israeli drugmaker Teva took a hit earlier this week when the company announced that its generics CEO, Siggi Olafsson, was leaving the company and would be replaced by...
15.11.2016
- The US Department of Justice (DOJ) is stepping up its broad criminal investigation into suspected price fixing for generic drugs. A Grand Jury probe in the two-year-old case is...
12.10.2016
- Mylan Pharmaceuticals, generics specialist headquartered in both the US and the UK, has paid $465m to the US government to settle claims that it improperly classified its EpiPen...
